Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c.
Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c.
复制标题
DOI：
10.1016/j.dsx.2021.02.010
复制
发表时间：
2021-01
期刊：
影响因子：
--
通讯作者：
Dickerson JA
中科院分区：
文献类型：
--
作者：
Roberts AJ;Malik F;Pihoker C;Dickerson JA
新冠肺炎大流行导致使用远程医疗提供非卧床糖尿病护理的情况迅速增长。这项研究评估了通过干血斑(DBS)测试进行远程HbA1c监测的可行性，以支持远程医疗访问的血糖控制评估，并检查了与患者完成DBS测试相关的临床和人口学特征。供应商可以在远程医疗访问前3周订购DBS HbA1c。通过检查DBS完成率、完成时间和远程医疗访问前DBS结果的可用性来评估可行性。使用卡方检验和Mann Whitney检验来评估完成率是否与参与者的特征有关。在2020年6月为远程医疗访问下的303个DBS订单中，162名患者完成了DBS测试，完成率为53.4%。从在家收集到报告结果的平均时间为6.9(3.8)天。在远程医疗诊所就诊之前，成功完成DBS的患者中有67.6%的患者可以获得DBS结果。DBS完成组的HbA1c低于未完成组(8.2%比8.9%，p<0.01)。两组患者的其他临床或人口学特征均无显著差异。通过DBS远程监测HbA1c是可行的，并为通过远程医疗观察的患者提供了一种支持血糖控制评估的途径。今后的工作应侧重于改进诊所和实验室流程，以支持远程DBS收集。
The COVID-19 pandemic has led to a rapid growth in the use of telemedicine for delivery of ambulatory diabetes care. This study evaluated the feasibility of remote HbA1c monitoring via dried blood spot (DBS) testing to support assessment of glycemic control for telemedicine visits and examined clinical and demographic characteristics associated with patient completion of DBS testing. Providers could place orders for DBS HbA1c 3 weeks prior to telemedicine visits. Feasibility was assessed by examining DBS completion rates, time to completion, and availability of DBS results prior to telemedicine visits. Chi-square tests and Mann Whitney tests were used to assess whether completion rates were associated with participant characteristics. Of 303 DBS orders placed for telemedicine visits in June 2020, 162 patients completed the DBS test for a completion rate of (53.4%). Average time from collection at home to result being reported was 6.9 (3.8) days. The DBS result was available in 67.6% of patients who completed successful DBS, before the telemedicine clinic visit. HbA1c was lower in the DBS completion group as compared to the non-completion group (8.2% vs. 8.9%, p = 0.01). No other clinical or demographic characteristics were significantly different between the two groups. Remote HbA1c monitoring via DBS is feasible and offers an avenue to support assessment of glycemic control for patients seen via telemedicine. Future work should focus on improving clinic and laboratory processes to support remote DBS collection.
登录
查看更多内容
影响因子：
16.2
作者：
Danne T;Nimri R;Battelino T;Bergenstal RM;Close KL;DeVries JH;Garg S;Heinemann L;Hirsch I;Amiel SA;Beck R;Bosi E;Buckingham B;Cobelli C;Dassau E;Doyle FJ 3rd;Heller S;Hovorka R;Jia W;Jones T;Kordonouri O;Kovatchev B;Kowalski A;Laffel L;Maahs D;Murphy HR;Nørgaard K;Parkin CG;Renard E;Saboo B;Scharf M;Tamborlane WV;Weinzimer SA;Phillip M
通讯作者：
Phillip M
影响因子：
5.7
作者：
Coronado, Gloria D.;Rivelli, Jennifer S.;Jimenez, Ricardo
通讯作者：
Jimenez, Ricardo
影响因子：
3.4
作者：
DiMeglio, Linda A.;Acerini, Carlo L.;Maahs, David M.
通讯作者：
Maahs, David M.
影响因子：
16.2
作者：
Cefalu, William T.;Berg, Erika Gebel;Robinson, Shamera
通讯作者：
Robinson, Shamera
影响因子：
16.2
作者：
通讯作者：
--